COVID-19 resources / Clinical Research Insights and News

The Cohortias Blog

Stay informed

COVID-19 resources

Cohortias is bringing clinical research to Latin America, now proud to participate in COVID-19 clinical trials.

Our archive includes insights from our experts as they discuss lessons learned over the past three months in managing COVID-19’s impact on trials in Latin America and around the world.

Our blog posts provide insights into what companies should be doing now to prepare for the upcoming ‘new normal’.

anvisa

Cohortias – ANVISA plans major medical device registration updates.

The changes will serve to strengthen the country’s medical device registration regulations.

travelers

Cohortias – Brazil is giving up COVID vaccine mandates for travelers.

A traveler is considered vaccinated against Covid when they have completed their primary vaccination series.

clinical research

Cohortias – Your ally to conduct clinical research in Latin America.

Mexico Has Immense Clinical Research Capabilities And Benefits. Conducting Clinical Trials In Mexico Grants You Affordable Costs And A Robust Regulatory System.

duchenne

Cohortias – FDA authorizes new duchenne muscular dystrophy trial.

The trial will enroll nearly 27 DMD patients aged four to nine years on stable corticosteroids at up to 12 US sites.

COVID-19 Research - Free Consultation

The clinical development journey is fraught with pitfalls and roadblocks; COVID-19 has almost overnight added to the complexity. Innovations, technologies and reinvented processes can help. Our experienced team of experts shares experiences, lessons learned and tips to help you mitigate risk in the current environment while implementing some of the industry’s latest innovations.

covid clinical trials

The presence of clinical research in Latin America has been growing steadily for the last decade, mainly because of cost effectiveness, excellent patient recruitment and the emergence of FDA approved regulatory agencies.